Notably, patients with suboptimal CD4+ T-cell recovery (persistent counts <200 cells/μL) demonstrated greater susceptibility to R-S cell development even during antiretroviral therapy (18), suggesting the critical role of sustained immunodeficiency in lymphomagenesis. Here, CD4 is linked to immunodeficiency disease.